- Home
- CCTG vs CLDI Comparison
CCTG vs CLDI Comparison
Compare CCTG & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTG
- CLDI
- Stock Information
- Founded
- CCTG 1993
- CLDI 2014
- Country
- CCTG Hong Kong
- CLDI United States
- Employees
- CCTG N/A
- CLDI N/A
- Industry
- CCTG
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCTG
- CLDI Health Care
- Exchange
- CCTG Nasdaq
- CLDI Nasdaq
- Market Cap
- CCTG 14.9M
- CLDI 15.7M
- IPO Year
- CCTG 2024
- CLDI N/A
- Fundamental
- Price
- CCTG $1.24
- CLDI $0.40
- Analyst Decision
- CCTG
- CLDI Strong Buy
- Analyst Count
- CCTG 0
- CLDI 2
- Target Price
- CCTG N/A
- CLDI $15.00
- AVG Volume (30 Days)
- CCTG 13.3K
- CLDI 202.0K
- Earning Date
- CCTG 12-27-2024
- CLDI 05-20-2025
- Dividend Yield
- CCTG N/A
- CLDI N/A
- EPS Growth
- CCTG N/A
- CLDI N/A
- EPS
- CCTG N/A
- CLDI N/A
- Revenue
- CCTG $16,463,490.00
- CLDI N/A
- Revenue This Year
- CCTG N/A
- CLDI N/A
- Revenue Next Year
- CCTG N/A
- CLDI N/A
- P/E Ratio
- CCTG N/A
- CLDI N/A
- Revenue Growth
- CCTG 3.27
- CLDI N/A
- 52 Week Low
- CCTG $1.16
- CLDI $0.35
- 52 Week High
- CCTG $3.17
- CLDI $4.90
- Technical
- Relative Strength Index (RSI)
- CCTG 41.06
- CLDI 36.62
- Support Level
- CCTG $1.19
- CLDI $0.40
- Resistance Level
- CCTG $1.28
- CLDI $0.46
- Average True Range (ATR)
- CCTG 0.07
- CLDI 0.04
- MACD
- CCTG 0.00
- CLDI 0.00
- Stochastic Oscillator
- CCTG 44.00
- CLDI 9.73
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.